William Ciambrone
Director/Board Member presso Massachusetts Biotechnology Education Foundation
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
William F.
Ciambrone is currently the Director at Massachusetts Biotechnology Education Foundation.
Previously, he held the position of Executive Vice President-Technical Operations at Sarepta Therapeutics, Inc. from 2019 to 2022 and at Shire Plc from 2013 to 2015.
He also served as Vice President-Quality at Shire Human Genetic Therapies, Inc. Mr. Ciambrone obtained his undergraduate degree from St. Anselm College.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 14/04/2023 | 8 509 ( 0.01% ) | 1 M $ | 31/03/2024 |
Posizioni attive di William Ciambrone
| Società | Posizione | Inizio |
|---|---|---|
Massachusetts Biotechnology Education Foundation
 Massachusetts Biotechnology Education Foundation Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Education Foundation supports science and biotechnology education in Massachusetts through school programs and workforce training. The company was founded in 2001 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Precedenti posizioni note di William Ciambrone
| Società | Posizione | Fine |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 31/12/2022 |
| SHIRE | Corporate Officer/Principal | 01/08/2015 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 01/01/2005 |
Formazione di William Ciambrone
| St. Anselm College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
Massachusetts Biotechnology Education Foundation
Massachusetts Biotechnology Education Foundation Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Education Foundation supports science and biotechnology education in Massachusetts through school programs and workforce training. The company was founded in 2001 and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- William Ciambrone
